AlphaFold predicted structure
MAF · O75444

Mean pLDDT
59.3/ 100
Low
373 residues
Confidence breakdown
- Very high(≥ 90)24%
- Confident(70–90)3%
- Low(50–70)17%
- Very low(< 50)55%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
MAF bZIP transcription factor
Annotations refreshed 12 hours ago.
Diagnostic Grade (Green)
Bilateral congenital or childhood onset cataracts
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownCorneal abnormalities
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedDDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownEarly onset or syndromic epilepsy
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedStructural eye disease
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedOcular coloboma
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedAymé-Gripp syndrome
early-onset non-syndromic cataract
prostate carcinoma
hereditary disease
cataract
thyroid gland carcinoma
multiple sclerosis
hypothyroidism
Cataract-microcornea syndrome
pulverulent cataract
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Transcription factor Maf
Acts as a transcriptional activator or repressor. Involved in embryonic lens fiber cell development. Recruits the transcriptional coactivators CREBBP and/or EP300 to crystallin promoters leading to up-regulation of crystallin gene during lens fiber cell differentiation. Activates the expression of IL4 in T helper 2 (Th2) cells. Increases T-cell susceptibility to apoptosis by interacting with MYB and decreasing BCL2 expression. Together with PAX6, transactivates strongly the glucagon gene promoter through the G1 element. Activates transcription of the CD13 proximal promoter in endothelial cells. Represses transcription of the CD13 promoter in early stages of myelopoiesis by affecting the ETS1 and MYB cooperative interaction. Involved in the initial chondrocyte terminal differentiation and the disappearance of hypertrophic chondrocytes during endochondral bone development. Binds to the sequence 5'-[GT]G[GC]N[GT]NCTCAGNN-3' in the L7 promoter. Binds to the T-MARE (Maf response element) sites of lens-specific alpha- and beta-crystallin gene promoters. Binds element G1 on the glucagon promoter. Binds an AT-rich region adjacent to the TGC motif (atypical Maf response element) in the CD13 proximal promoter in endothelial cells (By similarity). When overexpressed, represses anti-oxidant response element (ARE)-mediated transcription. Involved either as an oncogene or as a tumor suppressor, depending on the cell context. Binds to the ARE sites of detoxifying enzyme gene promoters
Curated MONDO disease pages that list MAF among their top associated genes.
MAF · O75444

Mean pLDDT
59.3/ 100
Low
373 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0